ZK381.2 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ZK381.2Glycosyltransferase family 92 protein ZK381.2 antibody; EC 2.4.1.- antibody
Target Names
ZK381.2
Uniprot No.

Target Background

Database Links

KEGG: cel:CELE_ZK381.2

UniGene: Cel.11610

Protein Families
Glycosyltransferase 92 family
Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is ZK381.2 and how does it relate to HIM-3 protein?

ZK381.2 is closely related to the open reading frame ZK381.1, which corresponds to the him-3 locus in Caenorhabditis elegans. The HIM-3 protein is a meiosis-specific component of chromosome cores with approximately 16% identity and 31% similarity to the amino-terminal portion of the yeast lateral element protein Hop1p . HIM-3 is a 291-amino-acid polypeptide with a predicted molecular mass of 33.1 kD that plays essential roles in chromosome synapsis and chiasma formation during meiosis .

What are the typical applications for ZK381.2/HIM-3 antibodies in research?

Based on research with similar antibodies, ZK381.2/HIM-3 antibodies are primarily used for:

  • Immunolocalization of proteins on meiotic chromosomes

  • Western blot analysis of protein expression and modification

  • Chromatin immunoprecipitation (ChIP) to study protein-DNA interactions

  • Immunoprecipitation to identify protein-protein interactions

  • Cytological analysis of meiotic progression

Antibodies raised against HIM-3 have been successfully used to localize the protein to condensing chromosomes in early prophase I and to the cores of both synapsed and desynapsed chromosomes .

What sample preparation methods are recommended for ZK381.2 antibody applications?

For optimal results with ZK381.2 antibody applications, researchers should consider:

Tissue Fixation and Preparation:

  • For immunohistochemistry: 4% paraformaldehyde fixation for preserved morphology

  • For Western blotting: Sample preparation in 1x PBS buffer with protease inhibitors

  • For immunoprecipitation: Gentle lysis conditions to maintain protein interactions

Protein Extraction Protocol:

  • Homogenize C. elegans samples in appropriate buffer (e.g., RIPA buffer)

  • Include protease inhibitors to prevent degradation

  • Centrifuge to remove debris

  • Quantify protein concentration before proceeding with applications

Similar to other research antibodies, purified antibodies are typically supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose for stability .

How should researchers validate the specificity of ZK381.2 antibodies?

Comprehensive validation of ZK381.2 antibodies should include:

Recommended Validation Steps:

  • Western blot analysis with positive and negative controls

  • Immunostaining patterns compared with known localization data

  • RNA interference (RNAi) depletion controls to confirm specificity

  • Testing on mutant strains lacking the target protein

  • Pre-absorption with immunizing peptide to confirm specificity

In previous studies with meiotic proteins, chromosomes appeared to condense normally in the absence of detectable protein after RNAi treatment, providing a useful negative control . Testing antibodies against tissues from knockout organisms provides the most stringent specificity control.

What controls are essential when using ZK381.2 antibodies in chromatin immunoprecipitation experiments?

When designing ChIP experiments with ZK381.2 antibodies, researchers should include:

Control TypePurposeImplementation
Input ControlNormalize for DNA amountReserve 5-10% of chromatin before immunoprecipitation
No Antibody ControlDetect non-specific bindingPerform IP procedure without antibody
IgG ControlMeasure backgroundUse same amount of non-specific IgG
Positive ControlVerify techniqueTarget known binding sites or proteins
Negative ControlVerify specificityUse primers for regions not expected to bind

Additionally, researchers should perform immunoprecipitation with an unrelated antibody from the same species to rule out non-specific binding due to the host species.

How can ZK381.2 antibodies be used to study meiotic chromosome dynamics in C. elegans?

ZK381.2/HIM-3 antibodies provide powerful tools for studying meiotic processes:

Advanced Applications:

  • Temporal profiling of protein localization: Track HIM-3 localization through meiotic stages

  • Co-immunoprecipitation: Identify interaction partners at different meiotic stages

  • Super-resolution microscopy: Analyze detailed chromosome core structures

  • ChIP-seq analysis: Map genome-wide binding patterns

  • In conjunction with live imaging: Correlate fixed and live cell observations

Research demonstrates that HIM-3 localizes to condensing chromosomes in early prophase I and remains associated with chromosome cores throughout synapsis and desynapsis , making antibodies against this protein valuable for studying meiotic progression.

What are the key considerations for multiplexing ZK381.2 antibodies with other meiotic protein markers?

When designing multiplexed immunostaining experiments:

Critical Factors:

  • Antibody compatibility: Ensure primary antibodies originate from different host species

  • Fluorophore selection: Choose fluorophores with minimal spectral overlap

  • Sequential staining: Consider sequential staining when using antibodies from the same species

  • Blocking optimization: Adjust blocking conditions to minimize cross-reactivity

  • Controls: Include single-antibody controls to assess bleed-through

For example, when combining antibodies against HIM-3 and synaptonemal complex proteins, researchers should carefully select antibodies raised in different host species (e.g., rabbit anti-HIM-3 and mouse anti-SYP-1) to allow clear discrimination with species-specific secondary antibodies.

How should researchers interpret changes in ZK381.2/HIM-3 localization in meiotic mutants?

Analysis of ZK381.2/HIM-3 localization patterns in meiotic mutants requires careful consideration:

  • Normal pattern: HIM-3 localizes to chromosome cores during early prophase and remains associated through synapsis and desynapsis

  • Interpretation of alterations:

    • Absence of localization may indicate upstream defects in chromosome condensation

    • Discontinuous localization suggests altered chromosome organization

    • Persistent localization in late prophase might indicate defects in protein removal

  • Comparisons with wild-type controls: Always process mutant and wild-type samples in parallel

  • Quantification approaches: Consider quantitative analysis of signal intensity and distribution

In previous studies, hypomorphic him-3 mutants show severe defects in chromosome segregation despite being proficient in synapsis , highlighting the importance of careful phenotypic interpretation.

What are common issues when using antibodies for C. elegans meiotic proteins and how can they be addressed?

Researchers frequently encounter these challenges:

IssuePossible CausesSolutions
High backgroundInsufficient blocking, antibody concentration too highOptimize blocking conditions, titrate antibody, use highly specific affinity-purified antibodies
No signalEpitope masking, inadequate fixationTry multiple fixation methods, include antigen retrieval steps
Non-specific bandsCross-reactivity, protein degradationUse affinity-purified antibodies, include protease inhibitors
Variable resultsBatch effects, inconsistent fixationStandardize protocols, use internal controls
Inconsistent IP resultsBuffer incompatibility, weak antibody-antigen interactionOptimize IP conditions, crosslink if necessary

When troubleshooting, researchers should consider that antibodies perform differently across applications. For example, an antibody that works well for Western blotting may fail in immunoprecipitation due to conformational requirements.

How can researchers differentiate between specific and non-specific signals when using ZK381.2 antibodies?

To distinguish specific from non-specific signals:

  • Compare with known localization patterns: HIM-3 should localize to chromosome cores in meiotic nuclei

  • Use genetic controls: Test antibody staining in him-3 mutants or RNAi-depleted samples

  • Perform peptide competition assays: Pre-incubate antibody with immunizing peptide

  • Compare multiple antibodies: If available, use antibodies targeting different epitopes

  • Correlate with functional data: Specific signals should correlate with known protein function

Researchers should be particularly cautious when interpreting signals in tissues where the protein is not expected to be expressed or when signals appear in cellular compartments inconsistent with known localization patterns.

What approaches can resolve contradictory results obtained with different antibody preparations against ZK381.2?

When faced with contradictory results:

  • Comprehensive validation: Re-validate each antibody using the methods described in question 2.1

  • Epitope mapping: Determine the exact epitopes recognized by each antibody

  • Post-translational modification analysis: Consider whether modifications affect epitope recognition

  • Isoform specificity: Determine whether antibodies recognize different protein isoforms

  • Orthogonal approaches: Use alternative methods (e.g., tagged proteins) to confirm results

For example, antibodies targeting different regions of a protein may give different results if:

  • One epitope is masked in certain protein complexes

  • Post-translational modifications alter epitope accessibility

  • Protein undergoes conformational changes in different cellular contexts

How can ZK381.2 antibodies contribute to understanding evolutionary conservation of meiotic processes?

ZK381.2/HIM-3 antibodies offer valuable tools for comparative studies:

  • Cross-species reactivity testing: Examine conservation across nematode species

  • Comparative localization studies: Compare chromosomal localization patterns across species

  • Functional complementation: Combine with transgenic studies expressing orthologs

  • Co-evolution analysis: Study interaction partners across species

The HIM-3 protein shares 16% identity and 31% similarity with the amino-terminal portion of yeast Hop1p , suggesting evolutionary conservation of chromosome core components that could be further explored with appropriate antibodies.

What are the emerging applications of combining ZK381.2 antibodies with advanced imaging techniques?

Integration of ZK381.2 antibodies with cutting-edge microscopy offers new research opportunities:

  • Super-resolution microscopy (SRM): Resolve fine structural details of chromosome cores

  • Expansion microscopy: Physically expand samples to increase effective resolution

  • Correlative light and electron microscopy (CLEM): Combine fluorescence and ultrastructural data

  • Single-molecule localization: Precisely map protein distribution within chromosome structures

  • Live-cell and fixed-cell correlation: Use antibodies to validate live imaging with fluorescent tags

These approaches could provide unprecedented insights into meiotic chromosome organization and dynamics beyond what conventional microscopy reveals.

How might ZK381.2 antibodies be utilized in studying chromosome dynamics in disease models?

ZK381.2/HIM-3 antibodies could contribute to disease-related research:

  • Meiotic defect models: Study chromosome segregation errors relevant to human aneuploidy

  • DNA repair pathway analysis: Examine relationships between chromosome cores and repair mechanisms

  • Cancer research applications: Investigate meiotic proteins aberrantly expressed in cancers

  • Aging studies: Explore age-related changes in meiotic chromosome dynamics

  • Reproductive biology: Analyze impacts of environmental factors on meiotic progression

Understanding meiotic chromosome dynamics has direct relevance to human reproductive health, and antibody tools for studying conserved components like HIM-3 could provide valuable insights into disease mechanisms.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.